Partnership
Partnership
Embedded Files
Partnership is at the heart of the current paradigm of drug discovery.
4Ammonium Biotech SL
Calle Torres Quevedo 15
28108-Alcobendas (SPAIN)
contact@4ammonium.com
Rafael Ferritto Crespo, PhD. (University of Lausanne, Switzerland) and Executive-MBA by Instituto de Empresa Madrid. Dr. Ferritto is founder of 4Ammonium Biotech SL, serves as Business Development Manager at Synthelia Organics SL and is co-founder of Nanoinnova Technologies SL. With more than 13 years of experience in multinational pharma in preclinical drug discovery (GSK and Eli Lilly).
Gonzalo Dorado, MS scientist at 4Ammonium deveoping new technologies for the nucleotide chemistry platform.
Synthelia Organics is a R&D company focussed on strong synthetic expertise in preclinical pharmaceutical development. Founded by former Lilly workers in Spain, Synthelia offers a great scope of services to Pharmaceuticals companies, API manufacturers and biotechs by synthesising intermediates and preclinical compounds including the design and development of new routes.
Enrique Jambrina, PhD scientist with expertise in early exploratory stages of drug development and new target identification; and experienced in the search and evaluation of innovative knowledge and technologies.
Ivoro Ventures Venture Builder in life sciences. Building startups our future needs.
Prof Belen Cid de la Plata is a organic chemistry professor at the Universidad Autónoma de Madrid with large experience in organic chemistry methodology and organo-catalysis.
Prof Mariola Tortosa Professor at the Universidad Autónoma de Madrid with large experience in organic chemistry methodology.
Page updated
Report abuse